Drugs

Article	Citations
Correction: Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments	502
Correction: New Pharmacologic Approaches to the Treatment of Bipolar Depression	464
Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema	375
Alcohol-Associated Liver Disease: Evolving Concepts and Treatments	236
Aprocitentan: First Approval	210
Clinical Efficacy, Safety and Imaging Effects of Oral Valiltramiprosate in APOEε4/ε4 Homozygotes with Early Alzheimer’s Disease: Results of the Phase III, Randomized, Double-Blind, Placebo-Controlled,	186
Senaparib: First Approval	178
Targeting DNA Damage Response Deficiency in Thoracic Cancers	166
Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using	142
Authors’ Reply to Toda: Multimodal Multidisciplinary Management of Patients with Moderate to Severe Pain in Knee Osteoarthritis: A Need to Meet Patient Expectations	141
Teclistamab: First Approval	139
Epcoritamab: First Approval	137
Eftrenonacog Alfa: A Review in Haemophilia B	128
Comment on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”	122
New Therapies on the Horizon for Primary Biliary Cholangitis	121
Spesolimab for the Treatment of Generalized Pustular Psoriasis	118
Asthma and Cardiovascular Diseases: Navigating Mutual Pharmacological Interferences	115
Vorasidenib: First Approval	107
Efficacy and Safety of Plecanatide in Chinese Patients with Functional Constipation: A Phase III Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial	104
Ivarmacitinib Sulfate: First Approval	103
Cosibelimab: First Approval	102
QT Prolongation and Risk of Death with the Use of Methadone for Chronic Cancer and Noncancer Pain: Myths or Reality?	101
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine	100
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2− Early Breast Cancer	99
Acoltremon: First Approval	95

Androgenetic Alopecia: Therapy Update	95
Drugs in Development to Manage Acute Pain	95
Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms	88
Atogepant: First Approval	87
Lenacapavir: First Approval	87
Safety of Anti-osteoarthritis Medications: A Systematic Literature Review of Post-marketing Surveillance Studies	84
Repotrectinib: First Approval	82
Danicopan: First Approval	82
Correction to: Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis	81
Olipudase Alfa: First Approval	81
Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?	81
Emerging Therapies for Chronic Hepatitis B and the Potential for a Functional Cure	81
Delgocitinib 20 mg/g Cream: A Review in Chronic Hand Eczema	78
Mazdutide: First Approval	78
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection	77
Cancer Pain Treatment Strategies in Patients with Cancer	75
Olverembatinib: First Approval	74
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification	69
Mosunetuzumab: First Approval	68
Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?	67
Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids	64
Correction to: Cefiderocol: A Review in Serious Gram-Negative Bacterial Infections	64
Managing Burning Mouth Syndrome: Current and Future Directions	64
Correction to: Tapinarof Cream 1%: First Approval	63
Situational Prevention of Migraine Attacks: Can Early Treatment Change the Conversation?	63
Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough	61
Correction to: Prevention and Treatment of Monkeypox	60
Correction to: Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes	60
Aligning Large Language Models with Humans: A Comprehensive Survey of ChatGPT’s Aptitude in Pharmacology	59
Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis	59
Treatment of Ovarian Cancer Beyond PARP Inhibition: Current and Future Options	58
Pozelimab: First Approval	58
Ifupinostat: First Approval	57
The Place of Cannabinoids in the Treatment of Gynecological Pain	57
Sunvozertinib: First Approval	57
Tovorafenib: First Approval	57
Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned	56
Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A	56
Dorzagliatin: First Approval	55
Correction to: Concizumab: First Approval	54
PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer	54
Focus on Metformin: Its Role and Safety in Pregnancy and Beyond	53
Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study	53
Catumaxomab: First Approval	52
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma?	52
Aumolertinib: A Review in Non-Small Cell Lung Cancer	50
Givinostat: First Approval	50
Ozoralizumab: First Approval	50
Birch Bark Extract: A Review in Epidermolysis Bullosa	49
Tirzepatide: A Review in Type 2 Diabetes	49

The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab	48
Correction to: Remdesivir: A Review in COVID-19	48
Asciminib: First Approval	47
Correction: From Prospective Evaluation to Practice: Model-Informed Dose Optimization in Oncology	47
Current Management of Peripheral Artery Disease: Focus on Pharmacotherapy	46
Pharmacotherapy for Dravet Syndrome: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials	45
Paracetamol Combination Therapy for Back Pain and Osteoarthritis: A Systematic Review and Meta-Analyses	43
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence	43
Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer’	42
Gepirone Extended-Release: First Approval	42
Correction to: Efmoroctocog Alfa: A Review in Haemophilia A	42
Current and Emerging Treatments for Acid Sphingomyelinase Deficiency	42
Ensitrelvir Fumaric Acid: First Approval	41
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy	41
Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults	41
Atrasentan: First Approval	41
Fezolinetant: First Approval	41
Futibatinib: First Approval	39
Tisotumab Vedotin: First Approval	39
Avacincaptad Pegol: First Approval	38
Correction: Teprotumumab: A Review in Thyroid Eye Disease	38
Omalizumab in Severe Asthma: Effect on Oral Corticosteroid Exposure and Remodeling. A Randomized Open-Label Parallel Study	38
Eye Involvement and Management in Inherited Epidermolysis Bullosa	37
Treatment of Non-Infectious Corneal Injury: Review of Diagnostic Agents, Therapeutic Medications, and Future Targets	37
Spondyloarthropathy in Inflammatory Bowel Disease: From Pathophysiology to Pharmacological Targets	37
Update on Mpox Management: Epidemiology, Vaccines and Therapeutics, and Regulatory Changes	37
Effectiveness of Interventions to Reduce Opioid Use After Orthopaedic Surgery: A Systematic Review of Randomised Controlled Trials	36
Advanced-Stage Chronic Myeloid Leukemia: Options for Difficult Treatment Situations	36
Tebentafusp: First Approval	35
Daratumumab: A Review in Newly Diagnosed Systemic Light Chain Amyloidosis	35
Correction: Lumasiran: A Review in Primary Hyperoxaluria Type 1	35
Imetelstat: First Approval	35
Managing Pain in Fibromyalgia: Current and Future Options	34
Correction: Iptacopan: First Approval	34
Safety of Janus Kinase Inhibitors in Inflammatory Bowel Diseases	34
Zastaprazan: First Approval	34
Recent United States Developments in the Pharmacological Treatment of Dry Eye Disease	33
Lotilaner Ophthalmic Solution 0.25%: First Approval	33
Beremagene Geperpavec: First Approval	33
Tamoxifen Dose De-Escalation: An Effective Strategy for Reducing Adverse Effects?	33
Varenicline Solution Nasal Spray: A Review in Dry Eye Disease	32
Gastrointestinal Dysfunction in Parkinson’s Disease	32
Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry	31
Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries	31
Correction to: Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues	31
Revolutionary Changes in the Management of Lupus Nephritis: Towards De-Glucocorticoid or No-Glucocorticoid	31
Acknowledgement to Referees	31
Mavorixafor: First Approval	30
Authors’ Reply to Mazza et al.: “Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence”	30
Efficiency and Safety of Noninvasive and Intravesical Therapy for Adult Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials	30
Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes	30
Retifanlimab: First Approval	30
Revumenib: First Approval	30
Targeting the Sphingosine-1-Phosphate Pathway: New Opportunities in Inflammatory Bowel Disease Management	29
Sepiapterin: First Approval	29
Diagnosis and Treatment of AL Amyloidosis	29
Botulinum Toxin-A for the Treatment of Myogenous Temporomandibular Disorders: An Umbrella Review of Systematic Reviews	29
Correction to: Abrocitinib: First Approval	28
Nogapendekin alfa Inbakicept: First Approval	28
Correction: Zastaprazan: First Approval	28
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update	28
Correction to: Sparsentan: First Approval	28
Crinecerfont: First Approval	28
Keverprazan Hydrochloride: First Approval	27
Antibacterials with Novel Chemical Scaffolds in Clinical Development	27
Methadone for Cancer Pain Management in Children: A Review of Literature	27
Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort Study	27
Onradivir: First Approval	27
Moderate-Intensity Statin Plus Ezetimibe: Time to Rethink it as an Optimal Initial Lipid-Lowering Strategy	27
Gabapentinoids for Pain: A Review of Published Comparative Effectiveness Trials and Data Submitted to the FDA for Approval	26
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy	26
Correction to: Spesolimab: First Approval	26
Combination of PARP Inhibitors and Androgen Receptor Pathway Inhibitors in Metastatic Castration-Resistant Prostate Cancer	26
Remdesivir: A Review in COVID-19	26
Ravulizumab: A Review in Generalised Myasthenia Gravis	25
Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis	25
Zolbetuximab: First Approval	25
Comment on: “Risk of Erectile Dysfunction in Male Patients with Gout Treated with Febuxostat or Allopurinol: A Propensity Score-Matched Cohort Study”	25
Efficacy and Safety of Sovateltide in Patients with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Clinical Trial	25
Daridorexant: First Approval	25

Novel Drug Therapeutics in Celiac Disease: A Pipeline Review

25